MOLECULAR STUDIES OF MUSCARINIC RECEPTOR SUBTYPES
MOLECULAR STUDIES OF MUSCARINIC RECEPTOR SUBTYPES
批准号:
2873196
负责人:
WILLIAM S MESSER
金额:
$16.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-01 至 2000-12-31
中文摘要
描述:(申请者摘要)乙酰胆碱能调节多种
中枢神经系统和全身的反应通过
毒鼠碱受体。M受体的五个亚型,属于
G蛋白偶联受体家族已经通过
分子生物学研究。尽管人们对生物化学的了解很多
以及由M受体引起或阻止的生理反应
配体,对激动剂之间的相互作用知之甚少
以及分子水平上具有M受体亚型的拮抗剂。
这些信息对于开发选择性配体的努力至关重要。
治疗阿尔茨海默病等神经系统疾病。
本提案侧重于了解配体之间的相互作用。
在分子水平上具有M受体亚型。分子
将使用建模和计算化学方法来开发
用于对接研究的M受体亚型模型。
生化研究将检查结合亲和力和激动剂
细胞内表达的M受体亚型配体的活性
台词。分子生物学方法将被用来产生受体
通过点突变进一步研究配体与Key的相互作用
M受体亚型上的氨基酸残基。化学合成
将集中在几个关键化合物上,目的是探索分子
对配体结合和活性很重要的特征。数量结构
活性研究将有助于确定分子特征
配体的活性,为合理设计和合成提供依据
新的配体。
拟议研究的总体目标是确定分子特征。
M受体对配体亲和力和激动剂活性的重要作用
子类型。这些研究将有助于产生新的化合物和
提高了对M受体亚型的选择性,并有助于
治疗阿尔茨海默病的新型配体的开发和应用
其他神经系统疾病。
英文摘要
DESCRIPTION: (Applicant's Abstract) Acetylcholine mediates a variety of
responses in the central nervous system and throughout the body via
muscarinic receptors. Five subtypes of muscarinic receptors, belonging to
the family of G-protein-coupled receptors, have been identified through
molecular biological studies. Although much is known about the biochemical
and physiological responses elicited or prevented by muscarinic receptor
ligands, comparatively little is known regarding the interaction of agonists
and antagonists with muscarinic receptor subtypes at the molecular level.
Such information is vital for efforts to develop selective ligands for the
treatment of neurological disorders such as Alzheimer's disease.
The present proposal focuses on understanding the interaction of ligands
with muscarinic receptor subtypes at the molecular level. Molecular
modeling and computational chemical approaches will be used to develop
models of muscarinic receptor subtypes for use in docking studies.
Biochemical studies will examine the binding affinities and agonist
activities of ligands at muscarinic receptor subtypes expressed in cell
lines. Molecular biological approaches will be used to generate receptors
with point mutations to examine further the interaction of ligands with key
amino acid residues on muscarinic receptor subtypes. Chemical synthesis
will focus on a few key compounds with the aim of exploring the molecular
features important for ligand binding and activity. Quantitative structure
activity studies will help identify the molecular features which contribute
to ligand activity and provide a basis for the rational design and synthesis
of new ligands.
The overall goal of the proposed studies is to identify molecular features
important for ligand affinity and agonist activity at muscarinic receptor
subtypes. These studies will be helpful in generating new compounds with
improved selectivity for muscarinic receptor subtypes, and aid in the
development of novel ligands for the treatment of Alzheimer's disease and
other neurological disorders.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors.
通过跨膜结构域 VI 和人 M(1) 毒蕈碱乙酰胆碱受体第三胞外环连接处的 Ser388Tyr 和 Thr389Pro 突变对激动剂效力和受体偶联进行差异调节。
DOI:
--
发表时间:
1999
期刊:
Molecular pharmacology
影响因子:
3.6
作者:
[Huang,XP, Williams,FE, Peseckis,SM, MesserJr,WS]
通讯作者:
MesserJr,WS
DOI:
10.1021/jm0102405
发表时间:
2001-11
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[W. G. Rajeswaran;Yang Cao;Xi-Ping Huang;M. E. Wroblewski;Tracy Colclough;Selina Lee;Fenghua Liu;Peter I. Nagy;James Ellis;Beth A. Levine;Karl H. Nocka;W. Messer]
通讯作者:
W. G. Rajeswaran;Yang Cao;Xi-Ping Huang;M. E. Wroblewski;Tracy Colclough;Selina Lee;Fenghua Liu;Peter I. Nagy;James Ellis;Beth A. Levine;Karl H. Nocka;W. Messer
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.
用于治疗阿尔茨海默病的选择性毒蕈碱激动剂的设计和开发:四氢嘧啶衍生物的表征和开发提高 M1 受体亲和力和选择性的新方法。
DOI:
10.1016/s0031-6865(99)00026-6
发表时间:
2000
期刊:
Pharmaceutica acta Helvetiae.
影响因子:
--
作者:
[MesserJr,WS, Rajeswaran,WG, Cao,Y, Zhang,HJ, el-Assadi,AA, Dockery,C, Liske,J, O'Brien,J, Williams,FE, Huang,XP, Wroblewski,ME, Nagy,PI, Peseckis,SM]
通讯作者:
Peseckis,SM
Theoretical studies of the in-solution isomeric protonation of non-aromatic six-member rings with two nitrogens.
含两个氮的非芳香六元环溶液内异构质子化的理论研究。
DOI:
10.1021/jp202241m
发表时间:
2011
期刊:
The journal of physical chemistry. B
影响因子:
--
作者:
[Nagy,PeterI, Messer,WilliamS]
通讯作者:
Messer,WilliamS
Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the bind
毒蕈碱激动剂四(乙二醇)(3-甲氧基-1,2,5-噻二唑-4-基)[3-(1-甲基-1,2,5,6-四氢吡啶-)新型衍生物的设计和合成
DOI:
10.1021/jm0606995
发表时间:
2006
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Tejada,FrederickR, Nagy,PeterI, Xu,Min, Wu,Cindy, Katz,Tricia, Dorsey,Jason, Rieman,Melissa, Lawlor,Elizabeth, Warrier,Manya, MesserJr,WilliamS]
通讯作者:
MesserJr,WilliamS
MOLECULAR STUDIES OF MUSCARINIC RECEPTOR SUBTYPES
-
批准号:2655535
-
项目类别:
-
资助金额:$15.72万
-
财政年份:1997
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF AMIDINES AS SELECTIVE MUSCARINIC AGONISTS
-
批准号:6258840
-
项目类别:
-
资助金额:$0.01万
-
财政年份:1997
-
负责人:WILLIAM S MESSER
-
依托单位:
MOLECULAR STUDIES OF MUSCARINIC RECEPTOR SUBTYPES
-
批准号:6248413
-
项目类别:
-
资助金额:$0.46万
-
财政年份:1997
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT SELECTIVE MUSCARINIC AGONISTS
-
批准号:6248412
-
项目类别:
-
资助金额:$0.46万
-
财政年份:1997
-
负责人:WILLIAM S MESSER
-
依托单位:
MOLECULAR STUDIES OF MUSCARINIC RECEPTOR SUBTYPES
-
批准号:2038268
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1997
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS
-
批准号:6187414
-
项目类别:
-
资助金额:$17.1万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
Muscarinic agonists for neurological disorders
-
批准号:7252510
-
项目类别:
-
资助金额:$21.8万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF AMIDINES AS SELECTIVE MUSCARINIC AGONISTS
-
批准号:2269099
-
项目类别:
-
资助金额:$19.38万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
Muscarinic agonists for neurological disorders
-
批准号:6824987
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS
-
批准号:2904490
-
项目类别:
-
资助金额:$17.64万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
Muscarinic agonists for neurological disorders
-
批准号:7087680
-
项目类别:
-
资助金额:$22.45万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS
-
批准号:6393520
-
项目类别:
-
资助金额:$17.61万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
Muscarinic agonists for neurological disorders
-
批准号:6895255
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS
-
批准号:6529565
-
项目类别:
-
资助金额:$18.14万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF AMIDINES AS SELECTIVE MUSCARINIC AGONISTS
-
批准号:2269098
-
项目类别:
-
资助金额:$16.15万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
DEVELOPMENT OF AMIDINES AS SELECTIVE MUSCARINIC AGONISTS
-
批准号:2269100
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1994
-
负责人:WILLIAM S MESSER
-
依托单位:
MULTIDISCIPLINARY STUDIES OF MUSCARINIC RECEPTORS
-
批准号:2259354
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1991
-
负责人:WILLIAM S MESSER
-
依托单位:
MULTIDISCIPLINARY STUDIES OF MUSCARINIC RECEPTORS (RCDA)
-
批准号:3075175
-
项目类别:
-
资助金额:$6.71万
-
财政年份:1991
-
负责人:WILLIAM S MESSER
-
依托单位:
MULTIDISCIPLINARY STUDIES OF MUSCARINIC RECEPTORS (RCDA)
-
批准号:3075177
-
项目类别:
-
资助金额:$6.82万
-
财政年份:1991
-
负责人:WILLIAM S MESSER
-
依托单位:
MULTIDISCIPLINARY STUDIES OF MUSCARINIC RECEPTORS (RCDA)
-
批准号:3075176
-
项目类别:
-
资助金额:$6.76万
-
财政年份:1991
-
负责人:WILLIAM S MESSER
-
依托单位: